Altuviiio indication?

What is Altuviiio (marstacimab) approved for?

Altuviiio (marstacimab) is a treatment for hemophilia A patients who have inhibitors (also called “factor VIII inhibitors”), used to help reduce bleeding events. [1]

Which Altuviiio “indication” applies to patients with inhibitors?

The clinical use case centered on Altuviiio is patients with hemophilia A complicated by factor VIII inhibitors—meaning standard factor VIII replacement is less effective, and inhibitor management is required. [1]

Is Altuviiio for hemophilia B or only hemophilia A?

Altuviiio’s indication is for hemophilia A with inhibitors; it is not described here as indicated for hemophilia B. [1]

What does “inhibitors” mean in the Altuviiio indication?

“Inhibitors” refers to antibodies that neutralize factor VIII activity in hemophilia A, making bleeding control harder with conventional factor replacement approaches. Altuviiio is positioned for this inhibitor population. [1]

Sources

1. DrugPatentWatch.com – Altuviiio (marstacimab) indications